ChemBriefAshland Explores Potential Sale
Ashland Inc. is exploring a potential sale, engaging investment banks Citigroup and Lazard to talk with strategic and financial suitors.
chemweek · 2026-08-12 03:08 UTC · 3 media covered
Ashland Inc. is exploring a potential sale, engaging investment banks Citigroup and Lazard to talk with strategic and financial suitors.
Ashland Inc. reported a 7% Q3 sales increase driven by volume and pricing actions to offset raw material costs, though EPS guidance was lowered due to tax rates. Growth was led by Life Sciences and Pe
Activist investor Ancora Holdings urges Ashland Inc., a specialty chemicals firm, to pursue a sale valued at $4.5 billion due to undervaluation. Potential buyers include Croda and Nouryon, while Ancor
Activist hedge fund Ancora Alternatives built a significant stake in specialty chemical firm Ashland Inc., urging a sale to unlock value. It threatened a proxy fight if progress stalls by September, f
Ashland Inc. reported a 48% drop in Q2 net income due to operational headwinds at its Hopewell facility, cutting full-year EBITDA guidance. Resilient demand in personal care and life sciences partiall